Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
NF-kappa B p50 Subunit | 8 | 2020 | 41 | 4.100 |
Why?
|
Brain Neoplasms | 15 | 2023 | 763 | 3.570 |
Why?
|
NF-kappa B | 7 | 2021 | 442 | 2.890 |
Why?
|
Glioma | 8 | 2019 | 285 | 2.500 |
Why?
|
Dacarbazine | 6 | 2018 | 102 | 2.410 |
Why?
|
Antineoplastic Agents, Alkylating | 6 | 2019 | 138 | 2.370 |
Why?
|
Glioblastoma | 6 | 2023 | 254 | 2.270 |
Why?
|
Hydrocephalus | 6 | 2022 | 101 | 1.530 |
Why?
|
DNA Damage | 6 | 2019 | 362 | 1.410 |
Why?
|
Genomic Instability | 2 | 2020 | 79 | 1.240 |
Why?
|
Cerebrospinal Fluid Shunts | 6 | 2022 | 48 | 1.220 |
Why?
|
Tumor Suppressor Proteins | 2 | 2020 | 279 | 1.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 1196 | 1.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2018 | 645 | 0.910 |
Why?
|
Cell Line, Tumor | 10 | 2021 | 2421 | 0.850 |
Why?
|
CDC2 Protein Kinase | 1 | 2021 | 45 | 0.790 |
Why?
|
Spinal Cord Compression | 2 | 2012 | 27 | 0.780 |
Why?
|
Receptors, Pattern Recognition | 1 | 2020 | 19 | 0.740 |
Why?
|
Dura Mater | 2 | 2012 | 44 | 0.720 |
Why?
|
DEAD-box RNA Helicases | 1 | 2020 | 62 | 0.710 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2018 | 589 | 0.710 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 165 | 0.710 |
Why?
|
Transcription Factors | 2 | 2018 | 1555 | 0.680 |
Why?
|
Supratentorial Neoplasms | 1 | 2018 | 10 | 0.670 |
Why?
|
Cell Cycle | 1 | 2020 | 502 | 0.660 |
Why?
|
Magnetite Nanoparticles | 1 | 2018 | 27 | 0.660 |
Why?
|
Dog Diseases | 1 | 2018 | 35 | 0.660 |
Why?
|
RNA, Long Noncoding | 1 | 2019 | 102 | 0.630 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 119 | 0.590 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 380 | 0.580 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2019 | 458 | 0.580 |
Why?
|
Drug Delivery Systems | 2 | 2018 | 178 | 0.560 |
Why?
|
Nanoparticles | 2 | 2018 | 157 | 0.560 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 1 | 2015 | 4 | 0.530 |
Why?
|
Animals | 21 | 2023 | 26518 | 0.530 |
Why?
|
Mice | 12 | 2023 | 11313 | 0.530 |
Why?
|
Aging, Premature | 1 | 2014 | 7 | 0.520 |
Why?
|
Binding Sites | 4 | 2021 | 1098 | 0.520 |
Why?
|
S Phase | 1 | 2015 | 62 | 0.510 |
Why?
|
Humans | 44 | 2023 | 86281 | 0.510 |
Why?
|
Promoter Regions, Genetic | 6 | 2021 | 937 | 0.500 |
Why?
|
DNA Replication | 1 | 2015 | 164 | 0.490 |
Why?
|
Haploinsufficiency | 1 | 2014 | 62 | 0.480 |
Why?
|
Multiple Myeloma | 1 | 2018 | 307 | 0.480 |
Why?
|
Brain | 6 | 2022 | 2211 | 0.480 |
Why?
|
Transcription Factor RelA | 2 | 2018 | 49 | 0.470 |
Why?
|
Hydrodynamics | 1 | 2022 | 18 | 0.450 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2007 | 683 | 0.450 |
Why?
|
Pituitary Neoplasms | 2 | 2019 | 62 | 0.450 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2012 | 22 | 0.440 |
Why?
|
Mice, Nude | 4 | 2019 | 790 | 0.390 |
Why?
|
Endoscopy | 3 | 2004 | 331 | 0.380 |
Why?
|
Convection | 3 | 2018 | 12 | 0.370 |
Why?
|
Aging | 1 | 2014 | 689 | 0.360 |
Why?
|
Cell Proliferation | 1 | 2015 | 1571 | 0.360 |
Why?
|
Signal Transduction | 1 | 2020 | 3233 | 0.350 |
Why?
|
DNA Methylation | 2 | 2023 | 622 | 0.340 |
Why?
|
Genetic Therapy | 4 | 2019 | 342 | 0.340 |
Why?
|
Spinal Neoplasms | 1 | 2008 | 50 | 0.330 |
Why?
|
Sacrum | 1 | 2008 | 38 | 0.330 |
Why?
|
Epidural Abscess | 1 | 2008 | 3 | 0.330 |
Why?
|
Leukemia, Hairy Cell | 1 | 2008 | 186 | 0.320 |
Why?
|
Eyebrows | 1 | 2008 | 10 | 0.320 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 2351 | 0.320 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2007 | 15 | 0.320 |
Why?
|
Infusion Pumps, Implantable | 1 | 2007 | 25 | 0.320 |
Why?
|
Alkylation | 2 | 2020 | 31 | 0.320 |
Why?
|
Orbit | 1 | 2008 | 37 | 0.310 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 148 | 0.310 |
Why?
|
Craniotomy | 1 | 2008 | 88 | 0.310 |
Why?
|
Phosphorylation | 3 | 2015 | 1101 | 0.300 |
Why?
|
Gene Transfer Techniques | 1 | 2007 | 152 | 0.300 |
Why?
|
Adenoviridae | 2 | 2007 | 345 | 0.300 |
Why?
|
Serine | 2 | 2020 | 99 | 0.300 |
Why?
|
Breast Neoplasms | 1 | 2020 | 2881 | 0.290 |
Why?
|
Craniopharyngioma | 1 | 2006 | 11 | 0.290 |
Why?
|
Wilms Tumor | 1 | 2006 | 38 | 0.290 |
Why?
|
Guanine | 1 | 2007 | 208 | 0.290 |
Why?
|
Spinal Cord Neoplasms | 1 | 2006 | 48 | 0.290 |
Why?
|
Cisterna Magna | 2 | 2022 | 10 | 0.280 |
Why?
|
Male | 17 | 2021 | 40860 | 0.280 |
Why?
|
Intracranial Pressure | 2 | 2022 | 77 | 0.280 |
Why?
|
Staphylococcal Infections | 1 | 2008 | 255 | 0.260 |
Why?
|
Neurosurgical Procedures | 3 | 2022 | 213 | 0.260 |
Why?
|
Ventriculostomy | 2 | 2004 | 26 | 0.260 |
Why?
|
Fibroblasts | 2 | 2020 | 729 | 0.260 |
Why?
|
Polymers | 2 | 2018 | 202 | 0.250 |
Why?
|
Pinealoma | 1 | 2004 | 4 | 0.250 |
Why?
|
Neurosurgery | 1 | 2005 | 84 | 0.250 |
Why?
|
Pineal Gland | 1 | 2004 | 14 | 0.250 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 3347 | 0.250 |
Why?
|
Cellular Senescence | 2 | 2015 | 94 | 0.250 |
Why?
|
Base Sequence | 2 | 2021 | 2329 | 0.250 |
Why?
|
Sella Turcica | 2 | 2019 | 17 | 0.240 |
Why?
|
Protein Binding | 3 | 2015 | 1454 | 0.240 |
Why?
|
Mice, Inbred C57BL | 3 | 2015 | 3087 | 0.240 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2022 | 54 | 0.210 |
Why?
|
Treatment Outcome | 8 | 2021 | 7949 | 0.210 |
Why?
|
Cell Death | 2 | 2014 | 256 | 0.210 |
Why?
|
Otolaryngology | 1 | 2022 | 53 | 0.210 |
Why?
|
Female | 14 | 2021 | 44405 | 0.210 |
Why?
|
Patient Satisfaction | 2 | 2022 | 452 | 0.200 |
Why?
|
Luciferases | 2 | 2015 | 118 | 0.200 |
Why?
|
Ambulatory Care Facilities | 1 | 2022 | 102 | 0.200 |
Why?
|
Time Factors | 7 | 2021 | 5198 | 0.200 |
Why?
|
Intracranial Thrombosis | 1 | 2001 | 26 | 0.200 |
Why?
|
Kidney Neoplasms | 1 | 2006 | 620 | 0.190 |
Why?
|
Ubiquitination | 1 | 2020 | 67 | 0.190 |
Why?
|
DNA Probes | 1 | 2020 | 77 | 0.190 |
Why?
|
Survival Analysis | 2 | 2018 | 1536 | 0.180 |
Why?
|
Protein Domains | 1 | 2020 | 128 | 0.180 |
Why?
|
Mice, Knockout | 2 | 2015 | 1918 | 0.180 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2001 | 136 | 0.180 |
Why?
|
Lysine | 1 | 2020 | 147 | 0.180 |
Why?
|
Drug Therapy | 1 | 2020 | 70 | 0.180 |
Why?
|
Tissue Plasminogen Activator | 1 | 2001 | 162 | 0.180 |
Why?
|
Cerebral Ventricles | 1 | 1999 | 76 | 0.180 |
Why?
|
Optic Chiasm | 1 | 2019 | 16 | 0.170 |
Why?
|
Fibrinolytic Agents | 1 | 2001 | 200 | 0.170 |
Why?
|
Transcription, Genetic | 3 | 2012 | 1135 | 0.170 |
Why?
|
Paraganglioma | 1 | 2019 | 16 | 0.170 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 220 | 0.170 |
Why?
|
Radiography | 2 | 2013 | 812 | 0.170 |
Why?
|
Interleukin-12 | 1 | 2019 | 108 | 0.170 |
Why?
|
DNA | 3 | 2014 | 1293 | 0.170 |
Why?
|
Carbonic Anhydrase II | 1 | 2018 | 4 | 0.170 |
Why?
|
Telemedicine | 1 | 2021 | 168 | 0.170 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 234 | 0.160 |
Why?
|
Astrocytoma | 1 | 2018 | 82 | 0.160 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2018 | 69 | 0.160 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 325 | 0.160 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 371 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 101 | 0.160 |
Why?
|
Vasospasm, Intracranial | 4 | 2001 | 36 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 2434 | 0.150 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 137 | 0.150 |
Why?
|
Dogs | 1 | 2018 | 684 | 0.150 |
Why?
|
Protein Multimerization | 1 | 2018 | 172 | 0.150 |
Why?
|
Tumor Burden | 1 | 2018 | 288 | 0.150 |
Why?
|
Child | 6 | 2022 | 6913 | 0.150 |
Why?
|
Neuroblastoma | 1 | 2020 | 374 | 0.150 |
Why?
|
Adenoma | 1 | 2019 | 234 | 0.150 |
Why?
|
Prognosis | 2 | 2019 | 3669 | 0.140 |
Why?
|
Radiation, Ionizing | 2 | 2014 | 121 | 0.140 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 857 | 0.140 |
Why?
|
Pilot Projects | 1 | 2018 | 837 | 0.130 |
Why?
|
Multivariate Analysis | 1 | 2018 | 997 | 0.130 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 10c | 1 | 2015 | 3 | 0.130 |
Why?
|
GPI-Linked Proteins | 1 | 2015 | 50 | 0.130 |
Why?
|
Comet Assay | 1 | 2015 | 8 | 0.130 |
Why?
|
Kyphosis | 1 | 2014 | 14 | 0.130 |
Why?
|
Disease Management | 1 | 2017 | 327 | 0.130 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2015 | 72 | 0.130 |
Why?
|
Gliosis | 1 | 2014 | 35 | 0.130 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 52 | 0.130 |
Why?
|
Immunoprecipitation | 1 | 2015 | 134 | 0.130 |
Why?
|
Longevity | 1 | 2014 | 51 | 0.130 |
Why?
|
Immunoblotting | 1 | 2015 | 267 | 0.120 |
Why?
|
Rats | 2 | 2013 | 3984 | 0.120 |
Why?
|
Transcriptional Activation | 1 | 2015 | 280 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2007 | 1680 | 0.120 |
Why?
|
DNA Primers | 1 | 2015 | 542 | 0.120 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2015 | 272 | 0.120 |
Why?
|
Middle Aged | 5 | 2021 | 24957 | 0.120 |
Why?
|
Apoptosis | 2 | 2014 | 1678 | 0.120 |
Why?
|
Pseudotumor Cerebri | 2 | 2004 | 16 | 0.120 |
Why?
|
RNA Interference | 1 | 2015 | 368 | 0.120 |
Why?
|
Heterozygote | 1 | 2014 | 365 | 0.120 |
Why?
|
Ferric Compounds | 1 | 2013 | 37 | 0.110 |
Why?
|
Bone and Bones | 1 | 2014 | 264 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 877 | 0.110 |
Why?
|
Down-Regulation | 1 | 2014 | 504 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 2594 | 0.110 |
Why?
|
Histones | 1 | 2014 | 309 | 0.110 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 1040 | 0.110 |
Why?
|
Nucleotides | 1 | 2012 | 95 | 0.110 |
Why?
|
Equipment Failure | 3 | 2022 | 118 | 0.110 |
Why?
|
Cell Differentiation | 1 | 2018 | 1456 | 0.100 |
Why?
|
Skull Base | 2 | 2022 | 47 | 0.100 |
Why?
|
Adult | 8 | 2021 | 25577 | 0.100 |
Why?
|
Brain Diseases | 2 | 2004 | 180 | 0.100 |
Why?
|
Gene Expression | 1 | 2015 | 1281 | 0.100 |
Why?
|
Cerebral Angiography | 5 | 2001 | 196 | 0.090 |
Why?
|
Hematoma | 2 | 2001 | 104 | 0.090 |
Why?
|
Age Factors | 1 | 2014 | 1842 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2014 | 1975 | 0.090 |
Why?
|
Genotype | 1 | 2014 | 1850 | 0.090 |
Why?
|
Infant | 4 | 2007 | 3036 | 0.090 |
Why?
|
Cells, Cultured | 1 | 2014 | 2810 | 0.090 |
Why?
|
Inflammation | 1 | 2014 | 913 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 1917 | 0.080 |
Why?
|
Cranial Fossa, Anterior | 1 | 2008 | 4 | 0.080 |
Why?
|
Pneumocephalus | 1 | 2008 | 10 | 0.080 |
Why?
|
Frontal Sinus | 1 | 2008 | 7 | 0.080 |
Why?
|
Phenotype | 1 | 2014 | 2375 | 0.080 |
Why?
|
Cell Line | 1 | 2012 | 2466 | 0.080 |
Why?
|
Subcellular Fractions | 1 | 2007 | 93 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2007 | 137 | 0.080 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 75 | 0.080 |
Why?
|
Parietal Bone | 1 | 2007 | 20 | 0.070 |
Why?
|
Drainage | 1 | 2008 | 157 | 0.070 |
Why?
|
DNA, Complementary | 1 | 2007 | 393 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2007 | 391 | 0.070 |
Why?
|
Child, Preschool | 3 | 2004 | 3608 | 0.070 |
Why?
|
Aged | 5 | 2023 | 18353 | 0.070 |
Why?
|
Fracture Fixation, Internal | 1 | 2007 | 65 | 0.070 |
Why?
|
Craniosynostoses | 1 | 2007 | 77 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 424 | 0.070 |
Why?
|
Frontal Lobe | 1 | 2006 | 130 | 0.070 |
Why?
|
Expert Testimony | 1 | 2005 | 46 | 0.070 |
Why?
|
Parietal Lobe | 1 | 2006 | 117 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2006 | 291 | 0.070 |
Why?
|
Sinusitis | 1 | 2008 | 209 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 1168 | 0.070 |
Why?
|
Adenoviruses, Human | 1 | 2004 | 41 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2004 | 32 | 0.060 |
Why?
|
Telemetry | 1 | 2004 | 38 | 0.060 |
Why?
|
Central Nervous System Cysts | 1 | 2004 | 9 | 0.060 |
Why?
|
Cerebral Arteries | 2 | 2001 | 74 | 0.060 |
Why?
|
Stroke | 1 | 2022 | 959 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2007 | 2227 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 1987 | 0.060 |
Why?
|
Tryptophan | 1 | 2022 | 90 | 0.050 |
Why?
|
Cell Survival | 1 | 2004 | 966 | 0.050 |
Why?
|
Office Visits | 1 | 2021 | 44 | 0.050 |
Why?
|
Macaca fascicularis | 4 | 2001 | 108 | 0.050 |
Why?
|
Adolescent | 3 | 2004 | 8968 | 0.050 |
Why?
|
Membranes, Artificial | 1 | 2001 | 40 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 169 | 0.050 |
Why?
|
Neoplasms | 2 | 2006 | 2889 | 0.050 |
Why?
|
Ferritins | 1 | 2000 | 29 | 0.050 |
Why?
|
Infusions, Intravenous | 1 | 2001 | 429 | 0.050 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2000 | 44 | 0.050 |
Why?
|
Biopsy | 1 | 2004 | 1160 | 0.050 |
Why?
|
Risk Assessment | 1 | 2007 | 2253 | 0.050 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 16 | 0.040 |
Why?
|
Cysts | 1 | 1999 | 103 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 6481 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2021 | 294 | 0.040 |
Why?
|
Thrombosis | 1 | 2001 | 296 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2001 | 306 | 0.040 |
Why?
|
Quality of Life | 1 | 2006 | 1575 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 464 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 263 | 0.040 |
Why?
|
Dexamethasone | 1 | 2019 | 326 | 0.040 |
Why?
|
Databases, Factual | 1 | 2021 | 808 | 0.040 |
Why?
|
Disease Progression | 2 | 2018 | 1531 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2021 | 8431 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2019 | 444 | 0.040 |
Why?
|
Reoperation | 1 | 1999 | 589 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 859 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 1671 | 0.040 |
Why?
|
Early Growth Response Protein 1 | 2 | 2006 | 54 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 632 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 1562 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 1305 | 0.030 |
Why?
|
Mutation | 1 | 2023 | 3952 | 0.030 |
Why?
|
Prospective Studies | 1 | 1999 | 4194 | 0.020 |
Why?
|
Hemoglobins | 2 | 2001 | 179 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2007 | 3616 | 0.020 |
Why?
|
Bone Wires | 1 | 2007 | 12 | 0.020 |
Why?
|
Genes, MDR | 1 | 2005 | 7 | 0.020 |
Why?
|
Tumor Necrosis Factors | 1 | 2005 | 14 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2006 | 438 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 555 | 0.010 |
Why?
|
Length of Stay | 1 | 2007 | 697 | 0.010 |
Why?
|
Lumbosacral Region | 1 | 2002 | 25 | 0.010 |
Why?
|
Peritoneal Cavity | 1 | 2002 | 21 | 0.010 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2002 | 22 | 0.010 |
Why?
|
Subarachnoid Space | 1 | 2001 | 17 | 0.010 |
Why?
|
Middle Cerebral Artery | 1 | 2001 | 20 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 2001 | 53 | 0.010 |
Why?
|
Basilar Artery | 1 | 2001 | 41 | 0.010 |
Why?
|
Potassium Chloride | 1 | 2001 | 86 | 0.010 |
Why?
|
Vasoconstriction | 1 | 2001 | 93 | 0.010 |
Why?
|
Vascular Patency | 1 | 2001 | 126 | 0.010 |
Why?
|
Syndrome | 1 | 2002 | 446 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 332 | 0.010 |
Why?
|
Heme Oxygenase-1 | 1 | 2000 | 19 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2000 | 290 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2001 | 987 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 912 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 1748 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 2369 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 2183 | 0.010 |
Why?
|